is a glp 1 ozempic More people with type diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness OZEMPIC: Risks, Benefits, and Natural

specifically, increasing villus height, crypt depth, improving nutrient absorption and nutritional status (Estall and Drucker, 2005)

All five treatment groups had reductions in absolute body weight and BMI at 24 weeks, but the exenatide and dapagliflozin group had greater weight loss than those receiving only dapagliflozin or dapagliflozin and metformin ( P = .005)

The most commonly reported adverse events are gastrointestinal reactions, including nausea, vomiting, diarrhea, and constipation, which typically occur during the early phase of treatment and tend to diminish or resolve with continued therapy (55, 56)

These medications can slow the emptying of the stomach, making people feel full longer, and suppress appetite by slowing hunger signals in the brain